Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belotecan + Cisplatin in Extensive-Stage Small-Cell Lung Cancer
NCT00754858Phase 2Completed
- Sponsor
- Yonsei University
- Start
- Oct 2008
- Primary completion
- May 2010
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of belotecan in small cell lung cancer (SCLC), sponsored by Yonsei University. Started Oct 2008; status: completed.
02
Drugs
belotecan
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00754858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00754858.